Mike Dineen, CEO of Tioga Cardiovascular, discusses the transcatheter mitral valve replacement (TMVR) landscape, early clinical experience with the Luna™ System and upcoming milestones with Joe Mullings.

The Luna System is for investigational use only and is not for sale in the U.S. or outside the U.S.